build1 distinct publisher
The FDA lets one phlebotomist supervise three autonomous blood-draw robots at once
Vitestro's Aletta is the first standalone blood-draw robot authorized in the United States. What builders will actually price is the supervision ratio the FDA attached to it and the 6% of patients the machine handed back to a human.
Publishers:runtimewire.com
Reality
- Evidence71
- Adoption21
- Hype gap+14
- Incentives77